Brief: Realheart Gets Patent Approval In India
Nov 20 (Reuters) - Scandinavian Real Heart AB
HEART.ST :
* REALHEART IS GRANTED PATENT APPROVAL IN INDIA FOR ITS
DEVICE
USED IN THE SURGICAL IMPLANTATION OF REALHEART® TAH
* DURATION OF PATENT (NO. 552361) IS 20 YEARS, WHICH WILL
THUS
EXPIRE IN APRIL 2042.
Source text: ID:nMFN1HRKp0
Further company coverage: HEART.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))